Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Gray

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Molecular Therapy. Methods & Clinical Development|December 3, 2025
Should patients with pre-existing anti-AAV antibodies be excluded from receiving intrathecally delivered AAV vectors?Steven J Gray
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 22, 2016
Timing of Gene Therapy Interventions: The Earlier, the BetterSteven J Gray
Discovery Medicine|December 23, 2017
Recent endeavors in MECP2 gene transfer for gene therapy of Rett syndromeSarah E Sinnett, Steven J Gray
Expert Opinion on Biological Therapy|June 14, 2008
Optimizing gene delivery vectors for the treatment of heart diseaseSteven J Gray, R Jude Samulski
Journal of Neuroscience Research|September 18, 2016
Immunological considerations for treating globoid cell leukodystrophySubha Karumuthil-Melethil, Steven J Gray
Brain Research|April 15, 2020
Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathiesRachel M Bailey, Alejandra Rozenberg, Steven J Gray
Advances in Genetics|October 15, 2014
Clinical applications involving CNS gene transferBoris Kantor, Thomas McCown, Paola Leone, et al.
Chemosensors (Basel, Switzerland)|May 4, 2026
Plasmonic Nanopore Sensing to Probe the DNA Loading Status of Adeno-Associated VirusesScott Renkes, Steven J Gray, Minjun Kim, et al.
Discovery Medicine|March 2, 2013
Recent gene therapy advancements for neurological diseasesSahana Nagabhushan Kalburgi, Nadia N Khan, Steven J Gray
Therapeutic Delivery|July 27, 2012
Viral vectors and delivery strategies for CNS gene therapySteven J Gray, Kenton T Woodard, R Jude Samulski
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Molecular Therapy. Methods & Clinical Development|December 3, 2025
Should patients with pre-existing anti-AAV antibodies be excluded from receiving intrathecally delivered AAV vectors?Steven J Gray
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 22, 2016
Timing of Gene Therapy Interventions: The Earlier, the BetterSteven J Gray
Discovery Medicine|December 23, 2017
Recent endeavors in MECP2 gene transfer for gene therapy of Rett syndromeSarah E Sinnett, Steven J Gray
Expert Opinion on Biological Therapy|June 14, 2008
Optimizing gene delivery vectors for the treatment of heart diseaseSteven J Gray, R Jude Samulski
Journal of Neuroscience Research|September 18, 2016
Immunological considerations for treating globoid cell leukodystrophySubha Karumuthil-Melethil, Steven J Gray
Brain Research|April 15, 2020
Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathiesRachel M Bailey, Alejandra Rozenberg, Steven J Gray
Advances in Genetics|October 15, 2014
Clinical applications involving CNS gene transferBoris Kantor, Thomas McCown, Paola Leone, et al.
Chemosensors (Basel, Switzerland)|May 4, 2026
Plasmonic Nanopore Sensing to Probe the DNA Loading Status of Adeno-Associated VirusesScott Renkes, Steven J Gray, Minjun Kim, et al.
Discovery Medicine|March 2, 2013
Recent gene therapy advancements for neurological diseasesSahana Nagabhushan Kalburgi, Nadia N Khan, Steven J Gray
Therapeutic Delivery|July 27, 2012
Viral vectors and delivery strategies for CNS gene therapySteven J Gray, Kenton T Woodard, R Jude Samulski
Pageof 11